Proteome profiling to advance management of metabolic dysfunction-associated fatty liver disease.

Eslam, Mohammed; Méndez-Sánchez, Nahum; Zheng, Ming-Hua

Eslam, Mohammed; Méndez-Sánchez, Nahum; Zheng, Ming-Hua.

Afiliação

Eslam M; Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Sydney, NSW, Australia.
Méndez-Sánchez N; Liver Research Unit, Medica Sur Clinic Foundation, Mexico City, Mexico.
Zheng MH; MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Hepatobiliary Surg Nutr ; 13(1): 147-149, 2024 Feb 01.

Article em En | MEDLINE | ID: mdl-38322223

Palavras-chave

Metabolic dysfunction-associated fatty liver disease (MAFLD); biomarkers; fatty liver disease (FLD); fibrosis; proteome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Hepatobiliary Surg Nutr Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google